Fostamatinib Seems Effective for Immune Thrombocytopenia

WEDNESDAY, Sept. 5, 2018 -- Fostamatinib produces clinically meaningful responses in adults with immune thrombocytopenia (ITP), according a study published in the July issue of the American Journal of Hematology. James Bussel, M.D., from Weill...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news